CLINICAL_TRIALS
trial_result
· 2025-11-26
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities [Phase 3]
Summary
Phase 3 trial of tirzepatide (LY3298176) in adults with obesity or overweight and weight-related comorbidities has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 3 | Status: COMPLETED | Results posted: 2025-11-26